PLACING ANTIMICROBIAL RESISTANCE IN THE CONTEXT OF COMPETING PUBLIC HEALTH PRIORITIES IN SUB-SAHARAN AFRICA, A PERSPECTIVE FROM MALAWI

Antimicrobial resistance is a major threat to human health that is predicted to impact most heavily on sub-Saharan Africa, however there is a lack of clinical outcome data from drug-resistant infections in this setting. There are reasons to expect the COVID-19 pandemic to have both positive and nega...

Full description

Bibliographic Details
Main Author: Nicholas Feasey
Format: Article
Language:English
Published: Elsevier 2023-05-01
Series:International Journal of Infectious Diseases
Online Access:http://www.sciencedirect.com/science/article/pii/S1201971223002345
_version_ 1827945239903469568
author Nicholas Feasey
author_facet Nicholas Feasey
author_sort Nicholas Feasey
collection DOAJ
description Antimicrobial resistance is a major threat to human health that is predicted to impact most heavily on sub-Saharan Africa, however there is a lack of clinical outcome data from drug-resistant infections in this setting. There are reasons to expect the COVID-19 pandemic to have both positive and negative impacts on AMR in Africa. We have recruited a series of prospective longitudinal cohorts from Queen Elizabeth Central Hospital (QECH), Blantyre, Malawi and the surrounding communities in the Southern Region of Malawi. The data from these cohorts has been used to describe the aetiology of febrile illness, the burden of antimicrobial resistance in this setting and the distribution of extended spectrum beta-lactamase producing bacteria in humans, animals and the environment. Amongst a cohort of patients presenting to QECH unwell with febrile illness, 67% were living with human immunodeficiency virus (HIV). We identified a diagnosis in 145 of 225 (64%) participants, most commonly tuberculosis (TB; 34%) followed by invasive bacterial infections (17%), arboviral infections (13%), and malaria (9%). In a second cohort with drug resistant infection, resistance to third-generation cephalosporins was associated with an increased probability of in-hospital mortality (hazard ratio [HR] 1·44, 95% CI 1·02–2·04), longer hospital stays (1·5 days, 1·0–2·0) and decreased probability of discharge alive (HR 0·31, 0·22–0·45). In the community cohorts, a paucity of environmental health infrastructure and materials for safe sanitation was identified across all sites and ESBL-Enterobacterales were isolated from 41.8% of human stool, 29.8% of animal stool and 66.2% of river water samples and was associated with the wet season, living in urban areas, advanced age and in household-animal interactions. Life threatening febrile illness is common in Blantyre however, diagnostics are few, however the COVID-19 pandemic has led to rapid expansion of diagnostic capacity. We are, however frequently treating the wrong bugs with ceftriaxone, further there was significant expansion of azithromycin demand and usage during the pandemic. Current management of sepsis has not been optimised and ceftriaxone use is promoting carriage of ESBL bacteria out of the hospital and ESBL E. coli and K. pneumoniae are ubiquitous in the community, where environmental hygiene infrastructure and community antimicrobial stewardship are critically lacking.
first_indexed 2024-03-13T10:40:49Z
format Article
id doaj.art-30d1f082be96439dab6fb4f6b19ad3c5
institution Directory Open Access Journal
issn 1201-9712
language English
last_indexed 2024-03-13T10:40:49Z
publishDate 2023-05-01
publisher Elsevier
record_format Article
series International Journal of Infectious Diseases
spelling doaj.art-30d1f082be96439dab6fb4f6b19ad3c52023-05-18T04:38:17ZengElsevierInternational Journal of Infectious Diseases1201-97122023-05-01130S44PLACING ANTIMICROBIAL RESISTANCE IN THE CONTEXT OF COMPETING PUBLIC HEALTH PRIORITIES IN SUB-SAHARAN AFRICA, A PERSPECTIVE FROM MALAWINicholas Feasey0Malawi Liverpool Wellcome Research Programme, Kamuzu University of Health Sciences & Liverpool School of Tropical MedicineAntimicrobial resistance is a major threat to human health that is predicted to impact most heavily on sub-Saharan Africa, however there is a lack of clinical outcome data from drug-resistant infections in this setting. There are reasons to expect the COVID-19 pandemic to have both positive and negative impacts on AMR in Africa. We have recruited a series of prospective longitudinal cohorts from Queen Elizabeth Central Hospital (QECH), Blantyre, Malawi and the surrounding communities in the Southern Region of Malawi. The data from these cohorts has been used to describe the aetiology of febrile illness, the burden of antimicrobial resistance in this setting and the distribution of extended spectrum beta-lactamase producing bacteria in humans, animals and the environment. Amongst a cohort of patients presenting to QECH unwell with febrile illness, 67% were living with human immunodeficiency virus (HIV). We identified a diagnosis in 145 of 225 (64%) participants, most commonly tuberculosis (TB; 34%) followed by invasive bacterial infections (17%), arboviral infections (13%), and malaria (9%). In a second cohort with drug resistant infection, resistance to third-generation cephalosporins was associated with an increased probability of in-hospital mortality (hazard ratio [HR] 1·44, 95% CI 1·02–2·04), longer hospital stays (1·5 days, 1·0–2·0) and decreased probability of discharge alive (HR 0·31, 0·22–0·45). In the community cohorts, a paucity of environmental health infrastructure and materials for safe sanitation was identified across all sites and ESBL-Enterobacterales were isolated from 41.8% of human stool, 29.8% of animal stool and 66.2% of river water samples and was associated with the wet season, living in urban areas, advanced age and in household-animal interactions. Life threatening febrile illness is common in Blantyre however, diagnostics are few, however the COVID-19 pandemic has led to rapid expansion of diagnostic capacity. We are, however frequently treating the wrong bugs with ceftriaxone, further there was significant expansion of azithromycin demand and usage during the pandemic. Current management of sepsis has not been optimised and ceftriaxone use is promoting carriage of ESBL bacteria out of the hospital and ESBL E. coli and K. pneumoniae are ubiquitous in the community, where environmental hygiene infrastructure and community antimicrobial stewardship are critically lacking.http://www.sciencedirect.com/science/article/pii/S1201971223002345
spellingShingle Nicholas Feasey
PLACING ANTIMICROBIAL RESISTANCE IN THE CONTEXT OF COMPETING PUBLIC HEALTH PRIORITIES IN SUB-SAHARAN AFRICA, A PERSPECTIVE FROM MALAWI
International Journal of Infectious Diseases
title PLACING ANTIMICROBIAL RESISTANCE IN THE CONTEXT OF COMPETING PUBLIC HEALTH PRIORITIES IN SUB-SAHARAN AFRICA, A PERSPECTIVE FROM MALAWI
title_full PLACING ANTIMICROBIAL RESISTANCE IN THE CONTEXT OF COMPETING PUBLIC HEALTH PRIORITIES IN SUB-SAHARAN AFRICA, A PERSPECTIVE FROM MALAWI
title_fullStr PLACING ANTIMICROBIAL RESISTANCE IN THE CONTEXT OF COMPETING PUBLIC HEALTH PRIORITIES IN SUB-SAHARAN AFRICA, A PERSPECTIVE FROM MALAWI
title_full_unstemmed PLACING ANTIMICROBIAL RESISTANCE IN THE CONTEXT OF COMPETING PUBLIC HEALTH PRIORITIES IN SUB-SAHARAN AFRICA, A PERSPECTIVE FROM MALAWI
title_short PLACING ANTIMICROBIAL RESISTANCE IN THE CONTEXT OF COMPETING PUBLIC HEALTH PRIORITIES IN SUB-SAHARAN AFRICA, A PERSPECTIVE FROM MALAWI
title_sort placing antimicrobial resistance in the context of competing public health priorities in sub saharan africa a perspective from malawi
url http://www.sciencedirect.com/science/article/pii/S1201971223002345
work_keys_str_mv AT nicholasfeasey placingantimicrobialresistanceinthecontextofcompetingpublichealthprioritiesinsubsaharanafricaaperspectivefrommalawi